New Delhi: The approval for Bharat Biotech’s Covaxin for use in the 2-18 years age group may take time before it is made available for people.
The Drugs Controller General of India (DCGI) is carefully examining the recommendation by the expert panel and evaluating several factors, Business Standard reported on Wednesday.
Last week, the panel had recommended the usage of Covaxin for children as young as two. The final approval for 2-18 years old is under expert opinion and evaluation.
The DCGI will hold discussions with the health minister, PMO, and Bharat Biotech before granting EUA to Covaxin, the report quoted sources as saying.
Bhubaneswar: A 20-year-old married woman, allegedly kidnapped from Odisha's Nabarangpur and then raped, and held…
New York: Slamming the prolonged delays in some parts of United States, Elon Musk on…
Cuttack: Madhupatana Police recently rescued a 17-year-old Bangladeshi girl, a suspected victim of trafficking and…
Mumbai: With the Bharatiya Janata Party (BJP), Shiv Sena and the NCP alliance emerging victorious in…
Balasore: The driver of a container truck was charred to death after the vehicle caught…
Nuapada: At least 80 people were arrested during a massive crackdown on illegal gambling activities…
Bhubaneswar: The Odisha government has transferred Special Secretary, Planning and Convergence, Chitra Arumugam and posted…
Sambhal: A violent clash erupted in Uttar Pradesh’s Sambhal on Sunday after a group opposed…